
Sign up to save your podcasts
Or


As we exit the first quarter of the 21st century, what are the big trends defining prescription drugs and how pharmacy benefits are administered? On the latest episode of the Pharmacy Insights Podcast, Optum Rx Senior Vice President of Clinical Consulting Scott Draeger welcomed Dr. John Wig, Chief Clinical Officer of Optum Rx, to discuss everything from new indications for GLP-1 medications to emerging biosimilar options for popular biologic drugs to the role of artificial intelligence in pharmacy care.
By Optum Rx5
1212 ratings
As we exit the first quarter of the 21st century, what are the big trends defining prescription drugs and how pharmacy benefits are administered? On the latest episode of the Pharmacy Insights Podcast, Optum Rx Senior Vice President of Clinical Consulting Scott Draeger welcomed Dr. John Wig, Chief Clinical Officer of Optum Rx, to discuss everything from new indications for GLP-1 medications to emerging biosimilar options for popular biologic drugs to the role of artificial intelligence in pharmacy care.

56,821 Listeners

369,836 Listeners

402 Listeners